- Home
- HLVX vs NKTR Comparison
HLVX vs NKTR Comparison
Compare HLVX & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLVX
- NKTR
- Stock Information
- Founded
- HLVX 2020
- NKTR 1990
- Country
- HLVX United States
- NKTR United States
- Employees
- HLVX N/A
- NKTR N/A
- Industry
- HLVX Biotechnology: Pharmaceutical Preparations
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- HLVX Health Care
- NKTR Health Care
- Exchange
- HLVX Nasdaq
- NKTR Nasdaq
- Market Cap
- HLVX 104.3M
- NKTR 108.3M
- IPO Year
- HLVX 2022
- NKTR 1994
- Fundamental
- Price
- HLVX $2.08
- NKTR $27.26
- Analyst Decision
- HLVX Hold
- NKTR Strong Buy
- Analyst Count
- HLVX 1
- NKTR 6
- Target Price
- HLVX $2.00
- NKTR $81.67
- AVG Volume (30 Days)
- HLVX 829.7K
- NKTR 673.7K
- Earning Date
- HLVX 08-06-2025
- NKTR 08-07-2025
- Dividend Yield
- HLVX N/A
- NKTR N/A
- EPS Growth
- HLVX N/A
- NKTR N/A
- EPS
- HLVX N/A
- NKTR N/A
- Revenue
- HLVX N/A
- NKTR $74,934,000.00
- Revenue This Year
- HLVX N/A
- NKTR N/A
- Revenue Next Year
- HLVX N/A
- NKTR N/A
- P/E Ratio
- HLVX N/A
- NKTR N/A
- Revenue Growth
- HLVX N/A
- NKTR N/A
- 52 Week Low
- HLVX $1.34
- NKTR $6.48
- 52 Week High
- HLVX $2.17
- NKTR $37.38
- Technical
- Relative Strength Index (RSI)
- HLVX 52.92
- NKTR 66.00
- Support Level
- HLVX $2.07
- NKTR $21.60
- Resistance Level
- HLVX $2.10
- NKTR $23.98
- Average True Range (ATR)
- HLVX 0.04
- NKTR 1.48
- MACD
- HLVX -0.01
- NKTR 0.22
- Stochastic Oscillator
- HLVX 50.00
- NKTR 86.67
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.